Evidence map›Paper›PMID 38130050›Full record

ArticleInternal medicine journal2023

Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial.

Marliese Alexander, Ian Collins, Patrick Abraham, Craig Underhill, Sam Harris, Javier Torres, Sharad Sharma, Benjamin Solomon, An Tran-Duy, Kate Burbury

Open access · hybridAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Marliese AlexanderPharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0001-5782-7912
Ian CollinsVictorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0001-6936-0942
Patrick AbrahamCentre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Craig UnderhillBorder Medical Oncology and Haematology Research Unit, Albury Wodonga Regional Cancer Centre, Albury Wodonga, New South Wales, Australia.ORCID 0000-0001-9335-2678
Sam HarrisBendigo Cancer Centre, Bendigo Health, Bendigo, Victoria, Australia.
Javier TorresPeter Copulos Cancer and Wellness Centre, Goulburn Valley Health, Shepparton, Victoria, Australia.
Sharad SharmaBallarat Regional Integrated Cancer Centre, Grampians Health, Ballarat, Victoria, Australia.
Benjamin SolomonSir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
An Tran-DuyCentre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Kate BurburySir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
The University of Melbourne · AUBallarat Health Services · AUBendigo Health · AUDeakin University · AUGoulburn Valley Health · AUUNSW Sydney · AU

Funding

National Health and Medical Research Council 1196211Peter MacCallum Cancer CentrePeter MacCallum Cancer FoundationVictorian Cancer Agency ECHSRF18006
6 · The paper itself

Abstract

This cost analysis, from a societal perspective, compared the cost difference of a networked teletrial model (NTTM) with four regional hubs versus conventional trial operation at a single metropolitan specialist centre. The Australian phase 3 cancer interventional randomised controlled trial included 152 of 328 regional participants (patient enrolment 2018-2021; 6-month primary end point). The NTTM significantly reduced (AU$2155 per patient) patient travel cost and time and lost productivity.

Indexed as

NeoplasmsTelemedicineAustraliaClinical Trials, Phase III as TopicCost-Benefit AnalysisCosts and Cost AnalysisHumansMedical OncologyRandomized Controlled Trials as Topiccancerclinical trialcost analysispatient costteletrial

Identifiers

PMID38130050
PMCPMC10946773
OpenAlexW4390110188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.